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Abstract
Non-Homologous End Joining (NHEJ) is one of the two major pathways of DNA Double Strand Breaks (DSBs) repair.
Mutations in human NHEJ genes can lead to immunodeficiency due to its role in V(D)J recombination in the immune
system. In addition, most patients carrying mutations in NHEJ genes display developmental anomalies which are likely the
result of a general defect in repair of endogenously induced DSBs such as those arising during normal DNA replication.
Cernunnos/XLF is a recently identified NHEJ gene which is mutated in immunodeficiency with microcephaly patients. Here
we aimed to investigate whether Cernunnos/XLF mutations disrupt the ability of patient cells to respond to replication
stress conditions. Our results demonstrate that Cernunnos/XLF mutated cells and cells downregulated for Cernunnos/XLF
have increased sensitivity to conditions which perturb DNA replication. In addition, under replication stress, these cells
exhibit impaired DSB repair and increased accumulation of cells in G2/M. Moreover Cernunnos/XLF mutated and down
regulated cells display greater chromosomal instability, particularly at fragile sites, under replication stress conditions. These
results provide evidence for the role of Cernunnos/XLF in repair of DSBs and maintenance of genomic stability under
replication stress conditions. This is the first study of a NHEJ syndrome showing association with impaired cellular response
to replication stress conditions. These findings may be related to the clinical features in these patients which are not due to
the V(D)J recombination defect. Additionally, in light of the emerging important role of replication stress in the early stages
of cancer development, our findings may provide a mechanism for the role of NHEJ in preventing tumorigenesis.
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Introduction
DNA Double Strand Breaks (DSBs) are one of the most
hazardous forms of DNA damage to the integrity of the genome.
DSBs arise from exogenous sources such as Ionizing Radiation
(IR) but can also be endogenously induced by the production of
reactive oxygen species or during normal DNA replication [1]. A
failure to repair DSBs could lead to cell death or to chromosomal
rearrangements [1]. There are two main DSB repair pathways,
the Homologous Recombination (HR) and the Non-Homologous
End Joining (NHEJ) which are conserved in eukaryotes from yeast
to human [1,2]. The NHEJ repair process begins with binding of
the DNA ends by the Ku70/Ku80 heterodimer and recruitment
of DNA-PK catalytic subunit (DNA-PKcs). This is followed by
processing of the DNA ends which involves Artemis and/or other
DNA processing enzymes. The final step is the ligation of the two
DNA ends by DNA Ligase IV, which acts in a complex together
with XRCC4 and Cernunnos/XLF that stabilize it and stimulate
its activity (for review see[3,4]).
Cernnunos/XLF is a recently discovered NHEJ core factor
which acts as part of the Ligase IV/XRCC4 complex and bares
structural similarity to XRCC4 [5,6]. Cernnunos/XLF has been
shown in vitro to stimulate the ligation process by the Ligase IV/
XRCC4 complex [7,8]. Cernnunos/XLF deficient mouse embry-
onic fibroblasts are highly sensitive to IR and show increased
chromosomal abnormalities implicating the importance of Cern-
nunos/XLF in preventing genomic instability under normal
growth conditions [9].
Mutations in the human Cernnunos/XLF gene cause combined
immunodeficiency, due to a defect in V(D)J recombination which
leads to decreased numbers of mature T- and B- lymphocytes
[5,10]. Fibroblasts from patients carrying Cernunnos/XLF
mutations are radio-sensitive and exhibit impaired DSB repair
following IR or radiomimetic drug treatment [5,6]. These results
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V(D)J recombination but also the repair of IR- induced DSBs.
Patients carrying Cernnunos/XLF mutations also display clinical
features which are not related to the immune system such as
growth retardation, microcephaly, various dysmorphic features
and malformations. In addition these patients show chromosomal
rearrangements, indicating difficulty in maintaining genomic
stability. All these phenotypes might indicate a defect in repair
of DSBs resulting from intrinsic sources such as DNA replication.
However, the role of Cernnunos/XLF in the repair of replication–
induced DSBs has not been studied, nor the effect of Cernnunos/
XLF mutations on the response to replication stress conditions.
Replication-induced DSBs are thought to be repaired primarily
through the HR pathway which uses a homologous chromatid or
chromosome for the repair [2] and therefore can readily repair
DSBs during DNA replication as the two sister chromatids are
localized in close proximity [11]. Nevertheless, the NHEJ repair
pathway also takes part in the repair of replication-induced DSBs
[12,13]. NHEJ deficient mammalian cells were shown to be more
sensitive to various replication stress inducing agents [12–14].
Moreover, we recently determined that the DNA-PKcs and Ligase
IV NHEJ factors are important for maintenance of common
fragile site stability under replication stress conditions [15].
Common fragile sites are the loci in the genome that are prone
to DSB formation under conditions of replication stress and are
involved in chromosomal rearrangements in tumors [16,17].
Therefore, we hypothesized that since Cernunnos/XLF has a role
in NHEJ which is not confined to V(D)J recombination,
Cernunnos/XLF mutations can lead to sensitivity to replication
stress and to increased fragile site instability
We tested this hypothesis by analyzing the cellular response to
replication stress conditions of cells from patients with immuno-
deficiency and microcephaly, caused by nonsense or framshift
mutations in the Cernnunos/XLF gene and in cells down
regulated for cells downregulated for Cernunnos/XLF by siRNA.
We demonstrate that the mutated and down regulated cells are
sensitive to replication stress conditions. Under mild replication
stress, the mutated as well as the downregulated Cernunnos/XLF
cells exhibit impaired DSB repair. We further show that under
replication stress conditions Cernnunos/XLF mutated cells display
increased chromosomal instability at common fragile sites. This
effect is most likely due to defective repair of replication-induced
DSBs and not due to perturbed replication since we found that the
replication rate in Cernunnos/XLF mutated cells is normal. These
results provide evidence for the importance of Cernunnos/XLF in
DSB repair, maintenance of genomic stability and survival under
replication stress conditions. Hence, we conclude that Cernunnos/
XLF mutations in immunodeficiency patients disrupt the ability of
cells to respond appropriately to replication stress conditions and
therefore may jeopardize the cells when they are hyperproliferat-
ing during embryonic development or in early stages of tumor
development.
Results
Cernunnos/XLF deficiency causes increased sensitivity to
replication stress
In order to test our hypothesis that Cernunnos/XLF mutations
disrupt the cellular response to replication stress we used a cell line
derived from a patient carrying a homozygous nonsense mutation
in the Cernunnos/XLF gene [5], which leads to complete absence
of the full length Cernunnos/XLF protein (Fig 1A). As a control
we used the same cells complemented with the wild type gene
(Fig 1A).
We first analyzed the survival of Cernunnos/XLF mutated and
complemented cells following treatment with aphidicolin, an
inhibitor of DNA polymerase a, d and e [18,19]. We found that
Cernunnos/XLF mutated cells are markedly more sensitive to
aphidicolin than their complemented counterparts (Fig 1B). This
was evident in low as well as high aphidicolin concentrations. A
similar experiment was performed on primary fibroblasts of the
same patient (P2) and on primary fibroblasts from another patient
(P3) carrying homozygous deletion G267 (K69fs) [5]. As a control,
we used primary fibroblasts derived from a T-B- SCID patient
with a mutation in the Rag1 gene and normal Cernunnos/XLF
alleles. Rag 1 is exclusively expressed in immature lymphocytes
therefore in these cells it is not expressed and has no effect on the
analyzed phenotypes. As can be seen in Fig 1C, the P2 and P3
primary cells are more sensitive to aphidiclin than the primay cells
with normal Cernunnos/XLF alleles, indicating that the sensitivity
to aphidicolin of the transformed cells is caused by the lack of
functionalCernunnos/XLFandnotduetothetransformationitself.
Together, our results indicate that Cernunnos/XLF is required
for cellular survival under conditions which perturb elongation of
DNA replication and that Cernunnos/XLF mutations found in
patients, disrutpt the cellular ability to cope with these conditions.
Cernunnos/XLF deficiency causes defect in the repair of
replication-induced DSBs
Cernunnos/XLF is a core factor of NHEJ hence we investigated
whether increased sensitivity to replication stress could be due to
impaired DSB repair. For this we analyzed the phosphorylation of
histone H2AX on Ser139 following aphidicolin treatment. Histone
H2AX undergoes phosphorylation in response to DSBs originat-
ing from diverse origins, including replication fork collapse [20–
22]. The degree of histone H2AX phosphorylation gives a fairly
accurate assessment of the extent of DSB repair [23].
Western blot analysis using an antibody directed against the
phosphorylated form of histone H2AX (cH2AX) was performed in
the Cernunnos/XLF mutated and complemented cell lines,
treated for 24 hours with low aphidicolin concentration, under
conditions that do not arrest DNA replication, and allowed to
recover in regular media for different times (Fig 2A, B). In both
Cernunnos/XLF mutated and complemented cells the level of
cH2AX increased significantly following the treatment (p,0.05)
and stayed high at the first two hours of recovery (Fig 2B). After 2
and 4 hours of recovery in Cernunnos/XLF complemented cells
cH2AX levels were significantly reduced (p,0.05) while in the
Cernunnos/XLF mutated cells cH2AX level was still high,
indicating an impaired repair of replication- induced DSBs in
the absence of Cernunnos/XLF. Interestingly, in untreated cells
the phosphorylation level of histone H2AX was higher in
Cernunnos/XLF mutated cells than in Cernunnos/XLF comple-
mented cells (Fig 2A). This could indicate that Cernunnos/XLF
mutations lead to a defect in repair of spontaneous DSBs even
under normal growth conditions. An impaired repair of replica-
tion-induced DSBs in the absence of Cernunnos/XLF was shown
also by cH2AX foci analysis, which represent sites of DNA
damage (Rogakou 1998,1999). The analysis was performed on BJ
cells, following 24 hours treatment with aphidicolin, in which the
Cernunnos/XLF protein was knocked down, using siRNA against
Cernunnos/XLF (Fig 2C, 2D). No increase in cell death was
observed in Cernunnos/XLF mutated cells after 24 hour
aphidicolin treatment compared to their complemented counter-
parts (data not shown), indicating that cell death can not explain
their higher cH2AX levels.
A delay in repair of replication–induced DSBs is expected to
affect cell cycle progression due to checkpoint activation, therefore
XLF and Replication Stress
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Aphidicolin can cause a change in cell cycle progression either
directly through the inhibition of DNA polymerases or indirectly
through activation of checkpoints in response to induced DNA
damage. The direct effect could cause lengthening of S-phase in
low concentrations, or arrest of cells along S-phase in high
concentrations. The indirect effect would lead to accumulation of
cells in S or G2/M due to activation of checkpoints. The cell cycle
distribution of Cernunnos/XLF mutated and complemented cell
lines was very similar in untreated cells (Fig 3A, B) despite
complete lack of NHEJ in the mutated cells [5]. In the lower
aphidicolin concentrations (0.2 mM and 0.5 mM), the percentage
of G2/M cells was significantly higher in Cernunnos/XLF
mutated cells compared with Cernunnos/XLF complemented
cells (p,0.05, Fig 3A, B), indicating higher levels of DNA damage
in Cernunnos/XLF mutated cells compared to their complement-
ed counterparts under the same conditions. In the higher
aphidicolin concentrations (1 mM and 4 mM) most of the cells
are stuck in the beginning of S-phase due to strong inhibition of
DNA polymerase, therefore the difference in the percentage of
G2/M cells seen between mutated and complemented cells is
small and insignificant. Thus, these results provide additional
support that Cernunnos/XLF deficiency leads to impaired repair
of replication-induced DSBs.
Replication-induced DNA damage was shown to activate the
cell cycle checkpoint protein, Chk1 [24]. It was recently
demonstrated that low concentrations of aphidicolin which do
not arrest DNA replication, activate the cell cycle checkpoint
protein, Chk1 [25]. Hence, we further analyzed the activation of
Chk1 in Cernunnos/XLF mutated and complemented cell lines
which were treated for 24 h with 0.5 mM aphidicolin, using an
antibody against phosphorylated Chk1 (Fig 4). In the Cernunnos/
XLF mutated cells the level of phosphorylated Chk1 increased
following the treatment, indicating the Chk1 is activated following
the replication stress conferred by aphidicolin. However, the
results clearly show a higher activation in Cernunnos/XLF
mutated and down regulated cells compared with the comple-
mented cells (Fig 4). These results indicate that in Cernunnos/
XLF mutated cells, the inability to efficiently repair replication-
induced DSBs leads to increased Chk1 activation.
Increased replication stress induced fragile site instability
in Cernunnos/XLF mutated cells
Common fragile sites are genomic loci which are specifically
unstable and appear as gaps and constrictions on metaphase
Figure 1. Cernunnos/XLF mutation leads to increased sensitiv-
ity to aphidicolin treatment. A. Western blot probed with an anti
Cernunnos/XLF antibody in U2OS cells MRC5 Cells, Cernunnos/XLF
mutated and Cernunnos/XLF complemented cells. The antibody
recognizes an epitope at the C-terminus of the protein which is found
beyond the premature stop-codon created by the nonsense mutation
in the Cernunnos/XLF mutated cells. The Cernunnos/XLF band is
slightly higher in the Cernunnos/XLF complemented cells compared
with other cells (U2OS and MRC5) since it is myc-tagged. B. Cernunnos/
XLF mutated and complemented cells were treated with the indicated
aphidicolin concentrations for 48 hours. Survival was assessed by crystal
violet staining. Data points represent mean and standard errors of two
independent experiments. The standard errors in Cernunnos/XLF
complemented cells are very small. C. Primary fibroblasts from P2, P3
and control primary fibroblasts were treated with the indicated
aphidicolin concentrations for 144 hours. Survival was assessed by
crystal violet staining. Data points represent mean and standard errors
of two independent experiments.
doi:10.1371/journal.pone.0004516.g001
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stress [26]. Previous studies have demonstrated the involvement of
proteins from the DNA damage response pathway in maintenance
of common fragile site stability. These include ATR, ATM,
CHK1, BRCA1, SMC1, FANCD2 and WRN [27,28] and
reviewed in [29]). Importantly, both HR and NHEJ DSB repair
pathways were shown to be important for the maintenance of
common fragile site stability under replication stress conditions
[15]. A number of human diseases resulting from mutations in
DNA damage response genes were shown to be associated with
increased instability at common fragile sites [28,30,31] however,
none of the diseases caused by mutations in the NHEJ factors were
studied. Therefore we investigated whether Cernunnos/XLF
mutations can lead to increased fragile site instability. For this
we analyzed formation of gaps and constrictions in metaphases
from Cernunnos/XLF mutated and complemented cell lines that
Figure 2. Cernunnos/XLF mutated or downregulated cells exhibit impaired repair of DSBs following treatment with low aphidicolin
concentrations. A. Cernunnos/XLF mutated and complemented cells were treated with 0.5 mM aphidicolin for 24 hours and were then transferred
to regular growth media for 0–240 minutes. Protein Extracts were prepared at the indicated times after transfer to regular media and analyzed by
immunoblotting with anti- cH2AX antibodies (a-cH2AX). Untreated cells were analyzed as control. B. Quantification of cH2AX levels in Cernunnos/
XLF mutated and complemented cells following 0.5 mM aphidicolin treatment for 24 hours and different recovery times. cH2AX level was normalized
to tubulin control and to untreated cells. Bars represent mean and standard error of three independent experiments C. Western blot probed with
anti- Cernunnos/XLF antibody in BJ cells transfected with siRNA against Cernunnos/XLF. Transfection with a nonspecic siRNA was analyed as a
control. Equal loading was confirmed by probing with an anti-Tubulin antibody. D. BJ cells transfected with siRNA against Cernunnos/XLF or non-
specific control siRNA following 0.5 mM aphidicolin treatment for 24 hours and at a recovery time of 240 minutes. Cells were fixed and stained with
anti cH2AX antibody.
doi:10.1371/journal.pone.0004516.g002
Figure 3. Cernunnos/XLF mutated cells exhibit Increased accumulation of cells in G2/M following treatment with low aphidicolin
concentrations. A. Cernunnos/XLF mutated and complemented cells were treated with the indicated aphidicolin concentrations for 24 hours,
fixed, stained with propidium iodide and analyzed by FACS for DNA content. B. Quantification of the percentage of cells in G2/M following
aphidicolin treatment. Bars represent mean and standard error of three independent experiments. The dashed line represents the approximate
percentage of cells in G2/M in untreated cells.
doi:10.1371/journal.pone.0004516.g003
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Cernunnos/XLF expression using siRNA. Following a 24 hours
treatment with low aphidicolin concentration, under conditions
that do not arrest DNA replication, cells carrying a Cernunnos/
XLF mutation showed a significantly higher level of gaps and
constrictions (,3 fold, Fig. 5A,C), compared with their comple-
mented counterparts (p,0.001) (Fig. 5B,C). In the Cernunnos/
XLF mutated cells most of the metaphases (.75%) showed .5
gaps and constrictions, including over 15% of the metaphases with
a high number of gaps and constrictions (.20), which were not
seen in the complemented cells (Fig. 5A, C).
It is known that most chromosomal gaps and constrictions
following aphidicolin treatment occur at fragile sites [26]. To
verify that the increase in gaps and constrictions, in Cernunnos/
XLF mutated cells is at common fragile sites, we analyzed the
cloned common fragile sites FRA3B and FRA16D, using
fluorescent in-situ hybridization (FISH) with specific probes for
these sites. Cernunnos/XLF deficiency led to 4.5-fold (p,0.001)
and 2-fold (p,0.001) increase in the occurrence of gaps and
constrictions at FRA3B and FRA16D respectively, under
conditions of replication stress, compared with complemented
cells (Fig. 5D). The frequency of gaps and constrictions in
untreated cells was extremely low (0.5 FS/ metaphase) and no
increase in their frequency was detected in Cernunnos/XLF
mutated cells compared to complemented cells (Fig. 5C). There-
fore analysis of gaps and constrictions at specific fragile sites was
not further analyzed, in untreated cells.
Normal replication rate in Cernunnos/XLF mutated cells
As mentioned above replication-induced DSBs are repaired by
both HR and NHEJ DSB repair pathways. A recent report by
Daboussi et al. showed that deficiency in HR factors in
mammalian cells results in slower replication fork progression
[32]. Here we examined a possible effect of Cernunnos/XLF
mutation on replication fork progression. For this we analyzed
replication rate in Cernunnos/XLF mutated and complemented
cell lines by DNA combing [33]. Nascent DNA was labeled in the
cells by an IododeoxyUridine (IdU) pulse followed by a
ChlorodeoxyUridine (CldU) pulse. Fork rate was calculated by
measuring replication signals visualized following fluorescent
detection of IdU and CldU on single DNA molecules which were
spread on silanized microscope slides (Fig. 6A). Average
replication rate and the distribution of fork rate were similar in
Cernunnos/XLF mutated and complemented cells (0.76+/
20.35 kb/min and 0.76+/20.31 kb/min respectively and
Fig. 6B). These results indicate that the absence of Cernunnos/
XLF does not affect replication fork progression.
Discussion
Here we provide evidence for the importance of Cernunnos/
XLF for DSB repair, maintenance of genomic stability and
survival under replication stress conditions. We found that cells
harboring a nonsense mutation in the Cernunnos/XLF gene from
human patients with immunodeficiency with microcephaly,
exhibit decreased survival following aphidicolin treatment, indi-
cating increased sensitivity to replication stress conditions (Fig 1B).
Since Cernunnos/XLF is a NHEJ factor, we speculated that the
increased cell death seen under replication stress conditions is
probably due to a defect in repair of replication-induced DSBs.
Indeed our results show that Cernunnos/XLF mutated cells
exhibit impaired DSB repair process and increased accumulation
of cells in G2/M following aphidicolin treatment (Fig 3).
Moreover, Cernunnos/XLF mutated cells display increased
chromosomal instability at common fragile sites following mild
replication stress conditions (Fig 5). This effect of Cernunnos/XLF
mutation on the stability of fragile sites was not the result of
perturbed replication progression as shown in Figure 6.
Several patients have been described in the literature harboring
mutations in the NHEJ factors Ligase IV, Artemis or Cernunnos/
XLF [5,34–38]. In the majority of the patients, mutations in any of
these genes leads to immunodeficiency, indicating the immediate
effect of mutations in NHEJ on V(D)J recombination. In many of
the cases, including those harboring mutations in Cernunnos/
XLF, patients are born with developmental anomalies, such as
microcephaly and growth retardation, and show chromosomal
instability. These phenotypes are probably not related to the V(D)J
recombination defect in the immune system, but rather likely
result from a general inability to repair spontaneous DSBs
occurring during embryonic development throughout the body.
One major source of spontaneous DSBs is the DNA replication
process. Indeed cells carrying mutations in DNA-PK were shown
to be deficient in repair of replication-induced DSBs [39]. Our
results provide the first evidence that a disease caused by
mutations in NHEJ genes is associated with defective response to
conditions which perturb DNA replication. The developmental
Figure 4. The Cernunnos/XLF mutation lead to an increased activation of Chk1 in response to replication stress. A. Cernunnos/XLF
mutated and complemented cells were treated with 0.5 mM aphidicolin for 24 hours. Protein extracts were prepared and analyzed by
immunoblotting with anti- pChk1(S317) antibodies. Untreated cells were analyzed as control. B. Quantification of pChk1(S317) levels in Cernunnos/
XLF mutated and complemented cells following 0.5 mM aphidicolin treatment for 24 hours. pChk1(S317) level was normalized to Tubulin control.
doi:10.1371/journal.pone.0004516.g004
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PLoS ONE | www.plosone.org 6 February 2009 | Volume 4 | Issue 2 | e4516Figure 5. Cernunnos/XLF mutation leads to increased common fragile site instability. A. Examples of metaphases from Cernunnos/XLF
mutated cells. A cell treated with 0.2 mM aphidicolin for 24 hours, showing a high number of gaps and constrictions (n=28). The box in the top left is
a magnification of the area marked in the picture. Arrows mark gaps and constrictions (top panel). An untreated cell showing no gaps and
constrictions (bottom panel). B. Examples of metaphases from Cernunnos/XLF complemented cells. A cell treated with 0.2 mM aphidicolin for
24 hours, showing an average number of gaps and constrictions (n=6). Arrows mark gaps and constrictions (top panel). An untreated cell showing
no gaps and constrictions (bottom panel). C. Number of gaps and constrictions per metaphase in Cernunnos/XLF mutated and complemented cells
with or without treatment with 0.2 mM aphidicolin for 24 hours. The data presented is based on two independent experiments. For each experiment,
at least 50 metaphases for each condition were analyzed. D. Frequency of chromosomal gaps and constrictions at common fragile sites (FS) FRA3B
and FRA16D following treatment with 0.2 mM aphidicolin for 24 hours in Cernunnos/XLF mutated and complemented cells. Bars represent mean and
standard error of two independent experiments. For each experiment, at least 50 hybridizations were analyzed.
doi:10.1371/journal.pone.0004516.g005
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result from inappropriate DSB repair and increased chromosomal
instability at times of replicative stress which may occur when cells
are hyperproliferating during development [40].
Studies in humans and mice raised the possibility that decreased
NHEJ activity plays a role in carcinogenesis. In both mice and
humans, NHEJ deficiency is associated with tumor development
[35,37,41–43]. Genetic analyses in several human malignancies
(germ cell tumors and high grade breast cancers among others)
revealed that over 30% of the tumors had deletions in the distal
portion of chromosome 13 harboring the Ligase IV gene (Helsinki
University CGH database, [44,45]). In addition, genotypic
polymorphisms in NHEJ genes (XRCC4, Ligase IV and Ku 70)
have been associated with increased risk to develop breast cancer
or glioma [46–48]. Since Cernunnos/XLF was only recently
identified, its association with cancer risk, in humans or mice, was
not yet studied. Moreover, cancer has not been reported in
patients carrying Cernunnos/XLF mutations but only few patients
were as of yet reported, of whom several already died from fatal
infections and the others are still young.
Recent studies demonstrated that the immediate event following
oncogene overexpression is hyperproliferation, associated with
replication perturbation and formation of replication-induced
DSBs [49,50]. The barrier to tumorigenesis is exerted by the DNA
damage response [51,52]. Therefore damage response factors,
involved in the cellular response to replication-induced DSBs, are
likely to act as caretakers of the genome during tumor
development. Here we show that cells from patients carrying
mutations in the NHEJ gene Cernunnos/XLF exhibit sensitivity to
replication stress and impaired repair of replication-induced DSBs.
In light of the crucial role of replication stress at the early stages of
cancerdevelopment,ourresultssuggestthattheimpairedresponseto
replication stress could be the mechanism by which defective NHEJ
contributestohumancarcinogenesis.Furthermore,ourresultsimply
thatCernunnos/XLFactsasacaretakerofgenomestabilityandcan
be a potential factor in the prevention of tumorigenesis.
The results from our fragile site analysis indicate that
Cernunnos/XLF is crucial for the maintenance of fragile site
stability under conditions which perturb DNA replication but not
under normal growth conditions (Fig 5C). This is in agreement
with our previous results showing that down-regulation of DNA-
PKcs or Ligase IV by RNAi increased fragile site instability only
under replication stress [15]. It is interesting to note that under
normal growth conditions Cernunnos/XLF mutated cells exhibit
higher H2AX phosphorylation level compared to the comple-
mented cells, indicating unrepaired spontaneous DSBs in
Cernunnos/XLF mutated cells. Nevertheless, these DSBs are
probably repaired eventually, perhaps due to increased activity of
other repair pathways or prolonged arrest in cell cycle checkpoints
allowing maintenance of fragile site stability. Importantly, Rad51,
a component of HR, has a role in maintaining fragile site stability
under both replication stress and normal growth conditions [15].
These results can suggest that the defect in repair of replication-
induced DSBs caused by NHEJ deficiency could be compensated
by HR, but not vice versa. Indeed, DNA-PKcs deficiency was
shown to result in increased repair of DSBs by HR [53]. Another
possibility is that HR has a role during normal progression of
DNA replication while NHEJ is important only when DNA
replication is perturbed. In support of the latter, a recent study
shows that defects in several HR factors (Rad51, BRCA2 or
XRCC2) affect replication fork progression [32], while we found
that Cernunnos/XLF deficiency has no effect on DNA replication
(Fig. 6). Our results suggest that the negative effect of Cernunnos/
XLF mutations on genome stability in immunodeficiency and
microcephaly patients would probably be prominent in hyperpro-
liferating cells when DNA replication could be occasionally
perturbed.
In summary, the results presented in this study demonstrate that
cells from patients carrying mutations in the Cernunnos/XLF
NHEJ gene have impaired ability to respond to replication stress.
This might explain the developmental anomalies which are not
related to V(D)J recombination in patients carrying mutations in
NHEJ genes. Moreover, our data suggest that the impaired
response to replication stress could be the mechanism by which
defective NHEJ contributes to human carcinogenesis.
Materials and Methods
Cells, growth conditions and treatment
Cernunnos/XLF mutated cells are SV40T-transformed, telo-
merase-immortalized fibroblasts from patient P2 as published [5].
Complementation of the Cernunnos/XLF mutated cells was
performed by transduction of the cells with pMND-Cernunnos-
Myc-IRES-GFP retroviral vector. Cells were grown in RPMI
medium supplemented with 10% fetal bovine serum. hTERT BJ1
cell line (CLONTECH) were grown in DMEM supplemented
with 10% fetal bovine serum. Aphidicolin treatment was
performed by growing cells for the indicated time in RPMI media
containing the indicated aphidicolin concentration.
Figure 6. Cernunnos/XLF mutation does not affect replication
rate. A. Example of a DNA fiber showing the labeled IdU pulse (green
signals and arrows) and the labeled CldU pulse (red signals and arrows).
The estimated origin of replication is marked by a black arrow. B.
Distribution of fork rate in untreated Cernunnos/XLF mutated and
complemented cells. The data presented is based on two independent
experiments. In each experiment at least 50 molecules each containing
at least two replication signals were analyzed for each cell line.
doi:10.1371/journal.pone.0004516.g006
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Survival assay
Cernunnos/XLF mutated and complemented cells were plated
on 96-well plate at a density of 4000 cells/well and aphidicolin
treatment was performed in triplicates for 48 hours. Primary
fibroblasts were plated on 96-well plate at a density of 6000 cells/
well and aphidicolin treatment was performed in triplicates for
144 hours. This longer aphidicolin treatment was required, since
theprimarycellsgrowsignificantlymoreslowlythanthetransformed
cells. Afterwards cells were washed with PBS, fixed in 3.7%
formaldehyde/PBS and stained for 30 minutes in 0.1% crystal
violet. After washing and drying the crystal violet staining, the dye
wasextractedby10%aceticacidandtheabsorbanceofeachwellwas
measured at 590 nm by a microplate reader (Tecan).
Western blot
15% and 10% Polyacrylamide gels were used for protein
separation and detection of cH2AX and Cernunnos/XLF and
phosphorelated S317 Chk1 respectively. The gel was transferred
to a nitrocellulose membrane and antibody hybridization and
chemiluminescence were performed according to standard
procedures. cH2AX was detected with mouse antibodies (Upstate
biotechnology). Cernunnos/XLF was detected with rabbit antibod-
ies (Bethyl laboratories) and phosphorelated S317 Chk1 (S-317) was
detected with rabbit antibodies (Cell Signaling technology). HRP-
conjugated anti-mouse and anti-rabbit secondary antibodies were
obtained from Jackson Immunoresearch laboratories.
Immunofluorescence
Cell were fixed in 3.7% formaldehyde/PBS for 10 min,
permeabilized with 0.5% Triton/PBS and blocked with 5%
BSA/PBS. The primary antibody used in this study was mouse
anti cH2AX (Upstate Biotechnology). Cy3 conjugated secondary
antibody was added (Jackson Immunoresearch Laboratories). The
DNA was stained with 2 mg/ml. Images was taken with a Bio-Rad
confocal microscope.
Cell cycle analysis
Following aphidicolin treatment, cells were harvested and fixed
in 70% chilled Ethanol overnight. Cells were then stained with
0.01 mg/ml propidium iodide and DNA content was analyzed by
flow cytometry (Becton Dickinson FACScalibur).
Chromosomes preparation and fragile site analysis
Cells were harvested after a 40 minutes treatment with 100 ng/
ml colchicine followed by a 40 minutes incubation in 0.4% KCl at
37uC and multiple changes of 3:1 methanol: acetic acid fixative.
Cells were dropped onto slides and slides were baked overnight at
37uC before FISH protocol. BAC clones crossing or within fragile
sites were used for FISH analysis. BAC 1O12 was used for FRA3B
and BAC 264L1 was used for FRA16D. Probes were labeled with
digoxigenin (DIG)-11-dUTP (Roche) by nick translation. DIG-
labeled probes were detected with fluorescein isothiocyanate
(FITC)-conjugated sheep anti-DIG specific antibodies (Roche)
and the signal was amplified using donkey anti-sheep Cy2
antibodies (Jackson Immunoresearch laboratories). DNA was
stained with propidium iodide. FISH on metaphase chromosomes
was performed as previously described [54].
Gaps and constrictions at fragile sites were analyzed using a
Nikon fluorescent microscope. For total gaps and constrictions, at
least 100 metaphases for each condition were analyzed. For
analysis of specific fragile sites, at least 100 hybridizations were
analyzed.
Replication analysis
Cells were pulse labeled for 30 min by replacing the normal
medium with pre-warmed medium containing 100 mM iodode-
oxyuridine (IdU).At the end of the first labeling period, cells were
washed twice with warm phosphate-buffered saline (PBS) and then
pulse labeled once more for 30 min with medium containing
100 mM chlorodeoxyuridine (CldU). Cells were then harvested
and genomic DNA was extracted and combed as previously
described [55]. Briefly, cells were resuspended in PBS at a
concentration of 10
7 cells/ml, mixed with an equal volume of 1%
low-melting point agarose and immediately poured into 100 ml
molds. Before use, DNA containing agarose blocks were washed in
TE buffer and melted in MES buffer followed by digestion of
agarose by b-agarase. Following combing of the DNA on silanized
cover slips, DNA was denatured in 1 M NaOH and replication
signals were detected by indirect immunofluorescence. The
primary antibodies used were mouse anti-BrdU (for detection of
IdU, Becton Dickinson) and rat anti-CldU (Novus Biologicals).
The secondary antibodies used were alexa fluor 488 goat anti-
mouse and alexa fluor 594 goat anti-rat (invitrogen). Slides were
mounted in Slowfade light antifade reagent (molecular probes) and
analyzed using an Olympus IX81 inverted fluorescence micro-
scope equipped with an Andor IXON-885 electron-multiplying
CCD camera using the Andor IQ software (Andor Bioimaging
Division, Morrisville, NC). For replication rate analysis at least a
100 molecules, each containing at least two replication signals
were analyzed for each cell line.
Statistical analysis
For comparison of total gaps and constrictions the Kolmogorov-
Smirnov two-sample test was used. For comparison of gaps and
constrictions at specific fragile sites Fisher’s test was used. For
statistical analysis of cH2AX level and percentage of G2/M cells,
t-test was used.
RNA interference
The siRNA sequence directed against Cernunnos/XLF was
constructed by IDT (Coralville, IA, USA) sequence: 59-CGCU-
GAUUCGAGAUCGAUUGATT-39
Nonspecific control oligo (Dharmacon, Lafayette, CO, USA)
contains 52% GC content similar to the GC content in the specific
oligo. Oligofectamine (Invitrogen, Carlsbad, CA, USA) was used
for transfection of these RNA oligos into Hela and BJ cells.
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